US private equity firm Avista Capital Partners has hired Brian Markison as a healthcare industry executive.
Markison has more than 30 years of experience in the pharmaceuticals sector, most recently as president and CEO of Fougera Pharmaceuticals, a dermatology-focused pharmaceuticals company that was spun off from Nycomed in 2011 and sold to Sandoz, the generics division of Novartis, in July 2012.
Thompson Dean, co-managing partner and CEO of Avista, said, “We have known and worked with Brian for years, and we are delighted to have him join our team. The healthcare sector has been a core strength for Avista since the firm’s inception. Brian’s operating expertise will be invaluable as we continue to support the growth of our current healthcare investments, while evaluating new opportunities in pharmaceuticals, medical devices, and healthcare services.”
In connection with his new position, Markison has joined the board of directors of Lantheus Medical Imaging, an Avista portfolio company.
Before leading Fougera, Markison was chairman and CEO of King Pharmaceuticals, which he joined as COO in March 2004, and was promoted to president and CEO later that year, and elected chairman in 2007. Prior to that, he, held various senior leadership positions at Bristol-Myers Squibb, including president of oncology, virology and oncology therapeutics network; president of neuroscience, infectious disease and dermatology; and senior vice president, operational excellence and productivity. He serves on the Board of Directors of Immunomedics, PharmAthene, and Rosetta Genomics, where he also serves as board chairman.
Avista’s healthcare portfolio includes medical devices company AngioDynamics, wound care developer ConvaTec, contract research organization INC Research, diagnostic imaging company Lantheus, drug delivery company Optinose, medical uniform supplier Strategic Partners and VWR International, a global distributor of equipment and consumable supplies to the laboratory sectors.
In addition, during its time at DLJ Merchant Banking Partners, the Avista team was involved in healthcare investments, including medical device companies Accellent and Kinetic Concepts; healthcare services companies Focus Diagnostics, Charles River Laboratories and Fisher Scientific International; and pharmaceutical companies Nycomed, Warner Chilcott and Prometheus Laboratories.
Copyright © 2012 AltAssets